Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-05

FDA Approved: ZILEUTON — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Zileuton (generic) by Rising Pharma Holdings, Inc. under ANDA204929.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zileuton (zileuton)

Snippet

SUPPL AP for ZILEUTON (ZILEUTON)